Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
4(100.0%)
4Total
Phase 2(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07538674Phase 2Not Yet Recruiting

Peiyuan Guben Tongluo Ointment for Elderly Sarcopenia

Role: collaborator

NCT07504536Phase 2Not Yet Recruiting

Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia

Role: collaborator

NCT07504562Phase 2Not Yet Recruiting

Knee Pain Ejiao Paste for Knee Osteoarthritis

Role: collaborator

NCT07478328Phase 2Not Yet Recruiting

Chaigui Longmu Ejiao Paste for Ischemic Heart Disease

Role: collaborator

All 4 trials loaded